The prevalence of diabetes was 25.1%, and of these participants, 2.7% were on insulin therapy, 60.7% received oral hypoglycemic agents (OHAs), 6.6% received both (insulin and OHAs), and 30% received no treatment. The gene discussed is INS; the disease is diabetes mellitus.